Novartis’ breast cancer drug LEEO11 gains breakthrough status
Drug will challenge Pfizer’s Ibrance
X
Novartis’ breast cancer drug LEEO11 gains breakthrough status
https://pharmaphorum.com/news/novartis-breast-cancer-drug-leeo11-gains-breakthrough-status/
